Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management

被引：0
|
作者：
Busacca, A. [1 ]
Scrivo, B. [1 ]
Giuffrida, E. [1 ]
Guida, L. [1 ]
Carrozza, L. [1 ]
Calvaruso, V. [1 ]
Cappello, M. [1 ]
机构：
[1] Univ Palermo, Gastroenterol & Hepatol Sect, PROMISE, Palermo, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P293
引用
收藏
页码：S299 / S299
页数：1
相关论文
共 50 条
  • [21] First or Second Biologic in Inflammatory Bowel Disease Combination Therapy or Monotherapy?
    Aoun, Roni
    Jabak, Suha
    Mourad, Fadi H.
    Francis, Fadi F.
    Regueiro, Miguel
    Hashash, Jana G.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (09) : 740 - 746
  • [22] Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease
    Hindryckx, Pieter
    Novak, Gregor
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 633 - 641
  • [23] Second-Line Biologic Therapy Persistence in a Multicentre Cohort of Inflammatory Bowel Disease Patients
    Doherty, J.
    Stack, R.
    Morain, N. O.
    Corcoran, R.
    Ryan, B.
    Doherty, G.
    Mc Namara, D.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I211 - I211
  • [24] Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
    van Liere, Elsa L. S. A.
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Warner, Ben
    Hayee, Bu
    Mateen, Bilal A.
    Nolan, Jonathan D.
    de Boer, Nanne K. H.
    Anderson, Simon H. C.
    Ansari, Azhar R.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 4008 - 4019
  • [25] Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
    Elsa L. S. A. van Liere
    Ahmed B. Bayoumy
    Chris J. J. Mulder
    Ben Warner
    Bu Hayee
    Bilal A. Mateen
    Jonathan D. Nolan
    Nanne K. H. de Boer
    Simon H. C. Anderson
    Azhar R. Ansari
    Digestive Diseases and Sciences, 2022, 67 : 4008 - 4019
  • [26] A Practical Approach to Managing Inflammatory Bowel Disease Patients
    Pham, Co Q. D.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 : 32 - 32
  • [27] First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study
    Anisdahl, Karoline
    Svatun Lirhus, Sandre
    Medhus, Asle W.
    Moum, Bjorn
    Melberg, Hans Olav
    Hoivik, Marte Lie
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (10) : 1163 - 1168
  • [28] Biologic Therapy as a First-Line Treatment in Patients with Psoriasis: An Unstudied Population
    Baniandres Rodriguez, O.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (07): : 579 - 579
  • [29] The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naive Inflammatory Bowel Disease Patients
    Crouwel, Femke
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Peters, Job H. C.
    Boekema, Paul J.
    Derijks, Luc J. J.
    de Boer, Sybrand Y.
    van de Meeberg, Paul C.
    Ahmad, Ishfaq
    Buiter, Hans J. C.
    de Boer, Nanne K.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (09) : 1492 - 1499
  • [30] Active tuberculosis in patients with inflammatory bowel disease after biologic therapy at university hospitals of Leicester
    Nigam, Gaurav
    Davies, Paul
    Dhiman, Paula
    Estcourt, Lise
    Grant-Casey, John
    Hearnsha, Sarah
    Jairath, Vipul
    Kumar, Bhaskar
    Leithead, Joanna
    Murphy, Mike
    Oakland, Kate
    Ratcliff, Elizabeth
    Stanley, Adrian J.
    Travis, Simon
    Uberoi, Raman
    Douds, Andy
    GUT, 2023, 72 (SUPPL_2) : A78 - A79
12345